These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


222 related items for PubMed ID: 35869803

  • 1. Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Guevara A, Nery AF, de Souza Carvalho Melhem M, Bonfietti L, Rodrigues AM, Hagen F, de Carvalho JA, de Camargo ZP, de Souza Lima BJF, Vicente VA, Hahn RC.
    Mycoses; 2022 Dec; 65(12):1146-1158. PubMed ID: 35869803
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.
    Coelho RA, Brito-Santos F, Figueiredo-Carvalho MHG, Silva JVDS, Gutierrez-Galhardo MC, do Valle ACF, Zancopé-Oliveira RM, Trilles L, Meyer W, Freitas DFS, Almeida-Paes R.
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006675. PubMed ID: 30048450
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O, León-Cachón RB, Pérez-Maya AA, Aguirre-Garza M, Moreno-Treviño MG, González GM.
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
    Gupta AK, Taborda PR, Sanzovo AD.
    Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: three cases with relevant improvement under voriconazole therapy.
    Criado PR, Careta MF, Valente NY, Martins JE, Rivitti EA, Spina R, Belda W.
    J Dermatolog Treat; 2011 Jun; 22(3):167-74. PubMed ID: 20666671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
    Deng S, Lei W, de Hoog GS, Yang L, Vitale RG, Rafati H, Seyedmousavi M, Tolooe A, van der Lee H, Liao W, Verweij PE, Seyedmousavi S.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
    Coelho RA, Alves GM, Figueiredo-Carvalho MHG, Almeida-Silva F, de Souza GR, Lourenço MCDS, Brito-Santos F, Amaral ACF, Almeida-Paes R.
    Mem Inst Oswaldo Cruz; 2022 Jun; 117():e220089. PubMed ID: 36102413
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS, Castro LG, Nunes RS, Gimenes VM, Cury AE.
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
    Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, Xi L.
    Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
    [Abstract] [Full Text] [Related]

  • 20. Nodular lesions of the buttock for 20 years: the challenge of chromoblastomycosis in non-endemic settings.
    Osborne W, Langman G, Ladoyanni E, Chue A.
    BMJ Case Rep; 2024 Mar 15; 17(3):. PubMed ID: 38490708
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.